Fig 2:

Waterfall Plot of Best Percentage Change from Baseline in Size of Target Lesions in Subjects with Both Baseline and Post-Baseline Measurements with Tumor Marker (AFP and hCG) integration

*Note: Subjects not included progressed clinically or with rising tumor markers and therefore did not have post-baseline imaging measurements

*Note: Only subjects with measurable radiographic disease at enrollment are included. Subjects enrolled based on rising tumor markers only are not included. This includes 2 subjects who had stable disease by tumor marker criteria but no measurable disease and therefore not included in this plot.